ملتقى طلاب وطالبات جامعة الملك فيصل,جامعة الدمام - عرض مشاركة واحدة - ارجو المساعدة بلييييييييييييييييييييييييييز

nurse_mohammad · 2009- 5- 17

medications :

Oral antidiabetic agents for patients with type 2 diabetes who do not achieve glucose control with diet and exercise only (see Table 25-2).

A) Act by a variety of mechanisms, including stimulation of insulin secretion from functioning beta cells, reduction of hepatic glucose production, enhancement of peripheral sensitivity to insulin, and reduced absorption of carbohydrates from the intestine.
B) Sulfonylureas and meglitinide analogues may cause hypoglycemic reactions.
C) Biguanides, alpha-glucosidase inhibitors, and meglitinide analogues may cause significant flatus and GI adverse effects.

Insulin therapy for patients with type 1 diabetes who require replacement (see Table 25-3, page 920).

A) May also be used for type 2 diabetes when unresponsive to diet, exercise, and oral antidiabetic therapy.
B) Hypoglycemia may result as well as rebound hyperglycemia (Somogyi effect).
C) Commonly results in increased appetite and weight gain.

2009- 5- 17	#5
nurse_mohammad :: مشرف سابق:: منتدى كلية العلوم الصحية بالأحساء الملف الشخصي: رقم العضوية : 16648 تاريخ التسجيل: Sun Dec 2008 العمر: 37 المشاركات: 619 الـجنــس : ذكــر عدد الـنقـاط : 3247 مؤشر المستوى: 77 بيانات الطالب: الكلية: خريج كلية العلوم الصحية بالأحساء التخصص: تمريض المستوى: خريج جامعي	رد: ارجو المساعدة بلييييييييييييييييييييييييييز medications : Oral antidiabetic agents for patients with type 2 diabetes who do not achieve glucose control with diet and exercise only (see Table 25-2). A) Act by a variety of mechanisms, including stimulation of insulin secretion from functioning beta cells, reduction of hepatic glucose production, enhancement of peripheral sensitivity to insulin, and reduced absorption of carbohydrates from the intestine. B) Sulfonylureas and meglitinide analogues may cause hypoglycemic reactions. C) Biguanides, alpha-glucosidase inhibitors, and meglitinide analogues may cause significant flatus and GI adverse effects. Insulin therapy for patients with type 1 diabetes who require replacement (see Table 25-3, page 920). A) May also be used for type 2 diabetes when unresponsive to diet, exercise, and oral antidiabetic therapy. B) Hypoglycemia may result as well as rebound hyperglycemia (Somogyi effect). C) Commonly results in increased appetite and weight gain.